The use of Artificial Intelligence (AI) in the medicinal product lifecycle

EMA is seeking stakeholder feedback on the draft reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle via an open consultation concerning human and veterinary medicines. This consultation aims to initiate the dialogue with all groups of stakeholders in this fast evolving field. During the consultation a workshop will be organised by EMA on 20-21 November 2023 on AI in the context of medicines.

Please provide feedback by 31 December 2023 using the dedicated form.

Current version

Draft reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle

Consultation dates: 19/07/2023 to 31/12/2023Draft: consultation openReference Number: EMA/CHMP/CVMP/83833/2023Summary:

EMA is seeking stakeholder feedback on the draft reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle via an open consultation concerning human and veterinary medicines. This consultation aims to initiate the dialogue with all groups of stakeholders in this fast evolving field. During the consultation a workshop will be organised by EMA on 20-21 November 2023 on AI in the context of medicines.

Please provide feedback by 31 December 2023 using the dedicated form.